Q: Can you comment on CF, EPS, sales, growth on the 4th Q and full year just reported today. Would you rate it a buy sell or hold after hitting a new high.
5i Research Answer:
Sales were $738.1-million for the quarter, up from $604.8-million a year earlier. The result was above expectations of $709.5-million. Earnings of $27.1-million or $3.97 per share compared to earnings of $21-million or $3.08 per share a year earlier. The expectation was for earnings of $3.86 per share. For the full year, EPS was $19.05, beating estimates of $17.89; sales were $2.6B, about 1% better than consensus, and EBITDA was $275M, about 3% better. The stock is showing very strong resilience this year, and its solid cash flow could make it a good place to hide out in from market turbulence. Considering its very low valuation, we would lean to BUY on this.